The Eastern Hepatobiliary Surgery Hospital (EHSH) was founded in 1956 by a group of three led by Dr. Meng-Chao Wu, a member of Chinese Academy of Sciences. It is now the most prestigious university hospital and research institute specializing in hepatic and biliary diseases. The hospital is a IIIA specialty hospital accredited by the Chinese Ministry of Health.
Over the years, they have performed nearly 17,000 hepatectomy cases, which have built the biggest case bank of liver cancer in the world. Now, they are doing clinical research on using the gamma knife radio-surgery to treat liver cancer.
Hepatoblastoma are more common in patients aged under 3 years old. In 1980s, 12 cases of huge hepatoblastoma (800-1300 g) in babies aged from 4-12 month had been removed, with only one mortality that happened two years later after the surgery. All other kids are still alive and one of them is 15 years old now.
Since 1978, the hospital has become a teaching and researching center in hepatobiliary surgery for PhDs, residents and fellows from all around the world, and the host site of many national and international conferences on tumours. The hospital has graduated 78 PhDs, and many fellows from overseas. In addition to clinical departments, the hospital also composes Tumour Immunology and Gene Research Institute, Biological Signal Transmission Research Center, Molecular Tumor Research Lab, Virus-Gene Therapeutic Lab. There are billions of dollars for their research fund received from the Chinese government and overseas. All the scientific researches will benefit their patients clinically in many ways. They have also won diverse prizes and awards.
